Physician profile
Steven C Poletti
NPI 1508841859
$2,982,320.41
in general payments reported to CMS, 2019-2025
9 companies · $442K in 2025
The $442K reported for 2025 was more than what 99% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402K · 2020: $405K · 2021: $454K · 2022: $480K · 2023: $443K · 2024: $355K · 2025: $442K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.2M · Consulting Fee: $16K · Food and Beverage: $1,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,222,719.40 |
| Consulting Fee | $16,000.00 |
| Food and Beverage | $1,258.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,982,091.17 | 2019-2025 | Rise-L . Rise-L A/L, Creo, Creo Mis Stabilization System |
| Si-Bone, INC. | $58.72 | 2021 | |
| Boston Scientific Corporation | $42.89 | 2024 | |
| Abbott Laboratories | $37.87 | 2022 | |
| Arteriocyte Medical Systems, INC. | $24.90 | 2024 | Magellan |
| Spinal Simplicity, LLC | $24.75 | 2022 | |
| Providence Medical Technology, INC. | $15.74 | 2019 | |
| Relievant Medsystems, INC. | $13.40 | 2023 | Intracept |
| Sanofi-Aventis U.S. LLC | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Poletti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.